Healthy Aging and Dementia: Two Roads Diverging in Midlife?

Dementia, particularly Alzheimer’s disease (AD), is a growing pandemic that presents profound challenges to healthcare systems, families, and societies throughout the world. By 2050, the number of people living with dementia worldwide could almost triple, from 47 to 132 million, with associated cost...

Full description

Bibliographic Details
Main Authors: Katie Irwin, Claire Sexton, Tarun Daniel, Brian Lawlor, Lorina Naci
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2018.00275/full
id doaj-ac8a0fe365d04631aed1907b4f9f98c2
record_format Article
spelling doaj-ac8a0fe365d04631aed1907b4f9f98c22020-11-24T22:19:34ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652018-09-011010.3389/fnagi.2018.00275412313Healthy Aging and Dementia: Two Roads Diverging in Midlife?Katie Irwin0Claire Sexton1Claire Sexton2Tarun Daniel3Brian Lawlor4Brian Lawlor5Lorina Naci6Lorina Naci7Department of Neuroscience, University of Georgia, Athens, GA, United StatesMemory and Aging Center, Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, United StatesOxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, United KingdomDepartment of Neuroscience, University of Georgia, Athens, GA, United StatesMercer’s Institute for Successful Ageing, St. James’s Hospital, Dublin, IrelandThe Global Brain Health Institute, Trinity College Dublin, Dublin, IrelandThe Global Brain Health Institute, Trinity College Dublin, Dublin, IrelandSchool of Psychology, Trinity College Dublin, Dublin, IrelandDementia, particularly Alzheimer’s disease (AD), is a growing pandemic that presents profound challenges to healthcare systems, families, and societies throughout the world. By 2050, the number of people living with dementia worldwide could almost triple, from 47 to 132 million, with associated costs rising to $3 trillion. To reduce the future incidence of dementia, there is an immediate need for interventions that target the disease process from its earliest stages. Research programs are increasingly starting to focus on midlife as a critical period for the beginning of AD-related pathology, yet the indicators of the incipient disease process in asymptomatic individuals remain poorly understood. We address this important knowledge gap by examining evidence for cognitive and structural brain changes that may differentiate, from midlife, healthy aging and pathological AD-related processes. This review crystallizes emerging trends for divergence between the two and highlights current limitations and opportunities for future research in this area.https://www.frontiersin.org/article/10.3389/fnagi.2018.00275/fullagingearly markersmidlifeAlzheimer’s diseasedementiacognition and brain structure
collection DOAJ
language English
format Article
sources DOAJ
author Katie Irwin
Claire Sexton
Claire Sexton
Tarun Daniel
Brian Lawlor
Brian Lawlor
Lorina Naci
Lorina Naci
spellingShingle Katie Irwin
Claire Sexton
Claire Sexton
Tarun Daniel
Brian Lawlor
Brian Lawlor
Lorina Naci
Lorina Naci
Healthy Aging and Dementia: Two Roads Diverging in Midlife?
Frontiers in Aging Neuroscience
aging
early markers
midlife
Alzheimer’s disease
dementia
cognition and brain structure
author_facet Katie Irwin
Claire Sexton
Claire Sexton
Tarun Daniel
Brian Lawlor
Brian Lawlor
Lorina Naci
Lorina Naci
author_sort Katie Irwin
title Healthy Aging and Dementia: Two Roads Diverging in Midlife?
title_short Healthy Aging and Dementia: Two Roads Diverging in Midlife?
title_full Healthy Aging and Dementia: Two Roads Diverging in Midlife?
title_fullStr Healthy Aging and Dementia: Two Roads Diverging in Midlife?
title_full_unstemmed Healthy Aging and Dementia: Two Roads Diverging in Midlife?
title_sort healthy aging and dementia: two roads diverging in midlife?
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2018-09-01
description Dementia, particularly Alzheimer’s disease (AD), is a growing pandemic that presents profound challenges to healthcare systems, families, and societies throughout the world. By 2050, the number of people living with dementia worldwide could almost triple, from 47 to 132 million, with associated costs rising to $3 trillion. To reduce the future incidence of dementia, there is an immediate need for interventions that target the disease process from its earliest stages. Research programs are increasingly starting to focus on midlife as a critical period for the beginning of AD-related pathology, yet the indicators of the incipient disease process in asymptomatic individuals remain poorly understood. We address this important knowledge gap by examining evidence for cognitive and structural brain changes that may differentiate, from midlife, healthy aging and pathological AD-related processes. This review crystallizes emerging trends for divergence between the two and highlights current limitations and opportunities for future research in this area.
topic aging
early markers
midlife
Alzheimer’s disease
dementia
cognition and brain structure
url https://www.frontiersin.org/article/10.3389/fnagi.2018.00275/full
work_keys_str_mv AT katieirwin healthyaginganddementiatworoadsdiverginginmidlife
AT clairesexton healthyaginganddementiatworoadsdiverginginmidlife
AT clairesexton healthyaginganddementiatworoadsdiverginginmidlife
AT tarundaniel healthyaginganddementiatworoadsdiverginginmidlife
AT brianlawlor healthyaginganddementiatworoadsdiverginginmidlife
AT brianlawlor healthyaginganddementiatworoadsdiverginginmidlife
AT lorinanaci healthyaginganddementiatworoadsdiverginginmidlife
AT lorinanaci healthyaginganddementiatworoadsdiverginginmidlife
_version_ 1725778451599720448